• This record comes from PubMed

Successful Posaconazole Therapy of Disseminated Alternariosis due to Alternaria infectoria in a Heart Transplant Recipient

. 2017 Apr ; 182 (3-4) : 297-303. [epub] 20161119

Language English Country Netherlands Media print-electronic

Document type Case Reports, Journal Article

Links

PubMed 27866319
DOI 10.1007/s11046-016-0094-4
PII: 10.1007/s11046-016-0094-4
Knihovny.cz E-resources

We report a case of phaeohyphomycosis caused by Alternaria infectoria in a 61-year-old heart transplant recipient with multiple skin lesions and pulmonary infiltrates. The infection spread via the haematogenous route from the primary cutaneous lesions into the lungs. The diagnosis was based on the histopathological examination, direct microscopy, skin lesion cultures and detection of Alternaria DNA in the bronchoalveolar lavage fluid using molecular methods. The treatment consisted of a combination of surgical excision and systemic antifungal therapy. Voriconazole was the first agent used but had a weak effect. Posaconazole was subsequently used to achieve a successful response. The isolate was identified as A. infectoria by sequencing of the rDNA ITS region and the partial β-tubulin gene.

See more in PubMed

Med Mycol. 2012 Jul;50(5):518-21 PubMed

Infect Dis Clin North Am. 2013 Jun;27(2):305-16 PubMed

Am J Transplant. 2002 Aug;2(7):678-83 PubMed

Mycologia. 2013 May-Jun;105(3):530-46 PubMed

Stud Mycol. 2015 Sep;82:1-21 PubMed

J Clin Microbiol. 2008 May;46(5):1793-803 PubMed

Clin Drug Investig. 2013 Feb;33 Suppl 1:S33-6 PubMed

J Nephrol. 2006 Sep-Oct;19(5):668-72 PubMed

Transpl Infect Dis. 2010 Jun;12 (3):242-50 PubMed

Haematologica. 2004 Feb;89(2):207-14 PubMed

Actas Dermosifiliogr. 2014 Oct;105(8):e51-4 PubMed

G Ital Dermatol Venereol. 2015 Feb;150(1):73-85 PubMed

Transpl Infect Dis. 2014 Apr;16(2):270-8 PubMed

Diagn Microbiol Infect Dis. 2010 Oct;68(2):177-80 PubMed

Stud Mycol. 2013 Jun 30;75(1):171-212 PubMed

Mol Plant Pathol. 2003 Jul 1;4(4):225-36 PubMed

Clin Microbiol Infect. 2014 Apr;20 Suppl 3:47-75 PubMed

J Clin Microbiol. 2001 May;39(5):1952-5 PubMed

J Antimicrob Chemother. 2009 Jun;63(6):1295-7 PubMed

Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):377-80 PubMed

Med Mycol. 2014 Aug;52(6):565-76 PubMed

Clin Infect Dis. 2002 Feb 15;34(4):467-76 PubMed

Med Mycol. 2013 Feb;51(2):196-202 PubMed

Rev Iberoam Micol. 2014 Apr-Jun;31(2):149-51 PubMed

Med Mycol. 2011 Jul;49(5):543-7 PubMed

Dermatol Ther. 2014 May-Jun;27(3):140-3 PubMed

Clin Microbiol Rev. 2010 Oct;23(4):884-928 PubMed

Int J Infect Dis. 2010 Sep;14 Suppl 3:e329-32 PubMed

Med Mycol Case Rep. 2015 Jan 29;8:1-4 PubMed

Clin Infect Dis. 2010 Apr 15;50(8):1091-100 PubMed

J Antimicrob Chemother. 2011 Nov;66(11):2585-7 PubMed

Transpl Infect Dis. 2009 Aug;11(4):330-2 PubMed

Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34 PubMed

Clin Vaccine Immunol. 2009 Mar;16(3):423-6 PubMed

Fungal Genet Biol. 2009 Sep;46(9):642-56 PubMed

Med Mycol. 2015 Jun;53(5):440-6 PubMed

Clin Microbiol Infect. 2008 Aug;14(8):734-46 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...